Sars
SARS News: Glencore-Motsepe Venture Loses Appeal, New Vaccine Findings on Omicron Variant
Find out the latest on Glencore and Patrice Motsepe's coal venture and the susceptibility of the BA.2.86 omicron subvariant to bivalent mRNA vaccines!
See more